US deal promises £5m sales for Surgical Innovations

The Leeds-based group, which makes devices for use in minimally invasive surgery, said it has signed a five-year extension to its agreement with SI US. In order to maintain exclusive rights, SI US has committed to distribute Surgical Innovation branded products worth at least $8m over the period.

SI US will distribute the group’s Logi and LogiCut product ranges together with its reusable line and has been granted first refusal to all future SI branded products for the next five years.

Surgical said it retains the right to manufacture and distribute all devices under the SI brand in all other markets.

Graham Bowland, chief executive of Surgical, said: “This agreement extension with SI US strengthens the group’s strategy of developing its Resposable portfolio in the strategically important US market and gives us confidence for the future.

“We look forward to developing our partnership with SI US over the next five years.”